Ask us about 3.7 seconds!
Ellenville Regional Hospital is committed to the fight against breast cancer. In offering the Genius exam, Ellenville Regional Hospital has a more accurate tool for breast cancer screening.
What if more women regularly received an annual breast mammogram? How many more cancers could be detected at an earlier stage? How many lives could possibly be saved? We are on a mission to help women live longer, healthier lives, all while delivering compassionate care. As pioneers in digital diagnosis, our patients' comfort and health is very important to us, and prevention screening is an essential part of that. The best protection is early detection; therefore, we are bringing the latest technology in mammography to Ellenville Regional Hospital, to continue providing the community with exceptional care. It’s this kind of treatment that brings women back to us time after time.
Introducing...The Genius™ 3D Mammography™ Exam by Hologic!
The Genius™ 3D Mammography™ exam was developed by Hologic, Inc., a worldwide leader in Women’s Health. Utilizing advanced breast tomosynthesis technology, Genius exams are clinically proven to significantly increase the detection of breast cancers, while simultaneously decreasing the number of women asked to return for additional testing. In addition, compression time is reduced to 3.7 seconds, the fastest in the industry!
How it works
Using the Selenia Dimensions Genius 3D System, The Genius™ 3D Mammography™ exam allows doctors to examine breast tissue layer by layer. So, instead of viewing all of the complexities of breast tissue in a flat image, as with conventional 2D mammography, fine details are more visible and no longer hidden by the tissue above or below. The Genius exam consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. More than 200 clinical studies have shown that by using this technology, doctors are able to screen for breast cancer with greater accuracy(1-7)*— which means better breast cancer detection and a reduced chance of being called back for additional screenings.
Why this machine?
A mammogram is the best way to detect cancer at its earliest stages. As the ONLY mammogram proven to be more accurate for women of all ages and breast densities (1, 2) compared to convential 2D mammograms, the Genius™ 3D exam is the most best choice when it comes to breast cancer screening.
The breast is a three-dimensional object composed of different structures located at different heights within the breast. These structures can overlap and cause confusion when viewed as a flat two-dimensional image. This confusion of overlapping of tissue is a leading reason why small breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. Using breast tomosynthesis technology, the Hologic system creates a 3-dimensional image of the breast structure, which enables radiologists to more clearly see through overlapping tissue to detect cancers, often at an earlier stage.
The Hologic system is the first FDA-approved breast tomosynthesis system in the U.S. Hologic Genius™ 3D Mammography™ exams are now available in all 50 states and over 50 countries. To date, more than 8 million women have been screened with this advanced screening system.
The Genius™ 3D Mammography™ exam provides better, earlier breast cancer detection compared to 2D alone.(1-7) It finds 20-65% more invasive breast cancers than 2D mammography alone.(1-7) Genius exams have also been proven to reduce unnecessary callbacks by up to 40%.(1-7)
Plus the Softer Mammogram!
In addition to the 3.7 seconds compression time of the new Genius™ 3D Mammography™ Exam, we now have the MammoPad breast cushion for our patients' extra comfort. The MammoPad breast cushion — often referred to as "the softer mammogram" — is a foam pad invisible to X-rays that makes a mammography exam more comfortable for patients, as well as warmer, without compromising the quality of the image.
- 50% reduction in discomfort in three out of four women.
- Proven to increase tissue acquisition.
We are excited to bring new advancements and technology to you. Won't you help support the latest innovation in healthcare and breast cancer prevention screening?
* *Compared to 2D mammography alone.
1. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005
2. Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41%(95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D mammograms acquired with the Hologic 3D Mammography System versus women receiving 2D FFDM mammograms only. 2014 Jun 25;311(24):2499-507.
3. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736.
4. Skaane P, Bandos A, Eben EB et al. Two view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
5. Bernardi D, Macaskill P, Pellegrini M et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
6. McDonald ES, Oustimov A, Weinstein SP et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.
7. Rafferty EA, Durand, MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.